Table of Contents United States Premature Labor Treatment Market Report 2018 1 Premature Labor Treatment Overview 1.1 Product Overview and Scope of Premature Labor Treatment 1.2 Classification of Premature Labor Treatment by Product Category 1.2.1 United States Premature Labor Treatment Market Size (Sales Volume) Comparison by Type (2013-2025) 1.2.2 United States Premature Labor Treatment Market Size (Sales Volume) Market Share by Type (Product Category) in 2017 1.2.3 Progesterone 1.2.4 OBE-022 1.2.5 Retosiban 1.2.6 Others 1.3 United States Premature Labor Treatment Market by Application/End Users 1.3.1 United States Premature Labor Treatment Market Size (Consumption) and Market Share Comparison by Application (2013-2025) 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Others 1.4 United States Premature Labor Treatment Market by Region 1.4.1 United States Premature Labor Treatment Market Size (Value) Comparison by Region (2013-2025) 1.4.2 The West Premature Labor Treatment Status and Prospect (2013-2025) 1.4.3 Southwest Premature Labor Treatment Status and Prospect (2013-2025) 1.4.4 The Middle Atlantic Premature Labor Treatment Status and Prospect (2013-2025) 1.4.5 New England Premature Labor Treatment Status and Prospect (2013-2025) 1.4.6 The South Premature Labor Treatment Status and Prospect (2013-2025) 1.4.7 The Midwest Premature Labor Treatment Status and Prospect (2013-2025) 1.5 United States Market Size (Value and Volume) of Premature Labor Treatment (2013-2025) 1.5.1 United States Premature Labor Treatment Sales and Growth Rate (2013-2025) 1.5.2 United States Premature Labor Treatment Revenue and Growth Rate (2013-2025) 2 United States Premature Labor Treatment Market Competition by Players/Suppliers 2.1 United States Premature Labor Treatment Sales and Market Share of Key Players/Suppliers (2013-2018) 2.2 United States Premature Labor Treatment Revenue and Share by Players/Suppliers (2013-2018) 2.3 United States Premature Labor Treatment Average Price by Players/Suppliers (2013-2018) 2.4 United States Premature Labor Treatment Market Competitive Situation and Trends 2.4.1 United States Premature Labor Treatment Market Concentration Rate 2.4.2 United States Premature Labor Treatment Market Share of Top 3 and Top 5 Players/Suppliers 2.4.3 Mergers & Acquisitions, Expansion in United States Market 2.5 United States Players/Suppliers Premature Labor Treatment Manufacturing Base Distribution, Sales Area, Product Type 3 United States Premature Labor Treatment Sales (Volume) and Revenue (Value) by Region (2013-2018) 3.1 United States Premature Labor Treatment Sales and Market Share by Region (2013-2018) 3.2 United States Premature Labor Treatment Revenue and Market Share by Region (2013-2018) 3.3 United States Premature Labor Treatment Price by Region (2013-2018) 4 United States Premature Labor Treatment Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018) 4.1 United States Premature Labor Treatment Sales and Market Share by Type (Product Category) (2013-2018) 4.2 United States Premature Labor Treatment Revenue and Market Share by Type (2013-2018) 4.3 United States Premature Labor Treatment Price by Type (2013-2018) 4.4 United States Premature Labor Treatment Sales Growth Rate by Type (2013-2018) 5 United States Premature Labor Treatment Sales (Volume) by Application (2013-2018) 5.1 United States Premature Labor Treatment Sales and Market Share by Application (2013-2018) 5.2 United States Premature Labor Treatment Sales Growth Rate by Application (2013-2018) 5.3 Market Drivers and Opportunities 6 United States Premature Labor Treatment Players/Suppliers Profiles and Sales Data 6.1 AMAG Pharmaceuticals Inc 6.1.1 Company Basic Information, Manufacturing Base and Competitors 6.1.2 Premature Labor Treatment Product Category, Application and Specification 6.1.2.1 Product A 6.1.2.2 Product B 6.1.3 AMAG Pharmaceuticals Inc Premature Labor Treatment Sales, Revenue, Price and Gross Margin (2013-2018) 6.1.4 Main Business/Business Overview 6.2 GlaxoSmithKline Plc 6.2.2 Premature Labor Treatment Product Category, Application and Specification 6.2.2.1 Product A 6.2.2.2 Product B 6.2.3 GlaxoSmithKline Plc Premature Labor Treatment Sales, Revenue, Price and Gross Margin (2013-2018) 6.2.4 Main Business/Business Overview 6.3 Juniper Pharmaceuticals Inc 6.3.2 Premature Labor Treatment Product Category, Application and Specification 6.3.2.1 Product A 6.3.2.2 Product B 6.3.3 Juniper Pharmaceuticals Inc Premature Labor Treatment Sales, Revenue, Price and Gross Margin (2013-2018) 6.3.4 Main Business/Business Overview 6.4 Kissei Pharmaceutical Co Ltd 6.4.2 Premature Labor Treatment Product Category, Application and Specification 6.4.2.1 Product A 6.4.2.2 Product B 6.4.3 Kissei Pharmaceutical Co Ltd Premature Labor Treatment Sales, Revenue, Price and Gross Margin (2013-2018) 6.4.4 Main Business/Business Overview 6.5 Lipocine Inc 6.5.2 Premature Labor Treatment Product Category, Application and Specification 6.5.2.1 Product A 6.5.2.2 Product B 6.5.3 Lipocine Inc Premature Labor Treatment Sales, Revenue, Price and Gross Margin (2013-2018) 6.5.4 Main Business/Business Overview 6.6 ObsEva SA 6.6.2 Premature Labor Treatment Product Category, Application and Specification 6.6.2.1 Product A 6.6.2.2 Product B 6.6.3 ObsEva SA Premature Labor Treatment Sales, Revenue, Price and Gross Margin (2013-2018) 6.6.4 Main Business/Business Overview ... 7 Premature Labor Treatment Manufacturing Cost Analysis 7.1 Premature Labor Treatment Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Price Trend of Key Raw Materials 7.1.3 Key Suppliers of Raw Materials 7.1.4 Market Concentration Rate of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Manufacturing Process Analysis of Premature Labor Treatment 8 Industrial Chain, Sourcing Strategy and Downstream Buyers 8.1 Premature Labor Treatment Industrial Chain Analysis 8.2 Upstream Raw Materials Sourcing 8.3 Raw Materials Sources of Premature Labor Treatment Major Manufacturers in 2017 8.4 Downstream Buyers 9 Marketing Strategy Analysis, Distributors/Traders 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Market Positioning 9.2.1 Pricing Strategy 9.2.2 Brand Strategy 9.2.3 Target Client 9.3 Distributors/Traders List 10 Market Effect Factors Analysis 10.1 Technology Progress/Risk 10.1.1 Substitutes Threat 10.1.2 Technology Progress in Related Industry 10.2 Consumer Needs/Customer Preference Change 10.3 Economic/Political Environmental Change 11 United States Premature Labor Treatment Market Size (Value and Volume) Forecast (2018-2025) 11.1 United States Premature Labor Treatment Sales Volume, Revenue Forecast (2018-2025) 11.2 United States Premature Labor Treatment Sales Volume Forecast by Type (2018-2025) 11.3 United States Premature Labor Treatment Sales Volume Forecast by Application (2018-2025) 11.4 United States Premature Labor Treatment Sales Volume Forecast by Region (2018-2025) 12 Research Findings and Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer

List of Tables and Figures Figure Product Picture of Premature Labor Treatment Figure United States Premature Labor Treatment Market Size (K Pcs) by Type (2013-2025) Figure United States Premature Labor Treatment Sales Volume Market Share by Type (Product Category) in 2017 Figure Progesterone Product Picture Figure OBE-022 Product Picture Figure Retosiban Product Picture Figure Others Product Picture Figure United States Premature Labor Treatment Market Size (K Pcs) by Application (2013-2025) Figure United States Sales Market Share of Premature Labor Treatment by Application in 2017 Figure Hospital Examples Table Key Downstream Customer in Hospital Figure Clinic Examples Table Key Downstream Customer in Clinic Figure Others Examples Table Key Downstream Customer in Others Figure United States Premature Labor Treatment Market Size (Million USD) by Region (2013-2025) Figure The West Premature Labor Treatment Revenue (Million USD) and Growth Rate (2013-2025) Figure Southwest Premature Labor Treatment Revenue (Million USD) and Growth Rate (2013-2025) Figure The Middle Atlantic Premature Labor Treatment Revenue (Million USD) and Growth Rate (2013-2025) Figure New England Premature Labor Treatment Revenue (Million USD) and Growth Rate (2013-2025) Figure The South of US Premature Labor Treatment Revenue (Million USD) and Growth Rate (2013-2025) Figure The Midwest Premature Labor Treatment Revenue (Million USD) and Growth Rate (2013-2025) Figure United States Premature Labor Treatment Sales (K Pcs) and Growth Rate (2013-2025) Figure United States Premature Labor Treatment Revenue (Million USD) and Growth Rate (2013-2025) Figure United States Premature Labor Treatment Market Major Players Product Sales Volume (K Pcs) (2013-2018) Table United States Premature Labor Treatment Sales (K Pcs) of Key Players/Suppliers (2013-2018) Table United States Premature Labor Treatment Sales Share by Players/Suppliers (2013-2018) Figure 2017 United States Premature Labor Treatment Sales Share by Players/Suppliers Figure 2017 United States Premature Labor Treatment Sales Share by Players/Suppliers Figure United States Premature Labor Treatment Market Major Players Product Revenue (Million USD) (2013-2018) Table United States Premature Labor Treatment Revenue (Million USD) by Players/Suppliers (2013-2018) Table United States Premature Labor Treatment Revenue Share by Players/Suppliers (2013-2018) Figure 2017 United States Premature Labor Treatment Revenue Share by Players/Suppliers Figure 2017 United States Premature Labor Treatment Revenue Share by Players/Suppliers Table United States Market Premature Labor Treatment Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018) Figure United States Market Premature Labor Treatment Average Price (USD/Pcs) of Key Players/Suppliers in 2017 Figure United States Premature Labor Treatment Market Share of Top 3 Players/Suppliers Figure United States Premature Labor Treatment Market Share of Top 5 Players/Suppliers Table United States Players/Suppliers Premature Labor Treatment Manufacturing Base Distribution and Sales Area Table United States Players/Suppliers Premature Labor Treatment Product Category Table United States Premature Labor Treatment Sales (K Pcs) by Region (2013-2018) Table United States Premature Labor Treatment Sales Share by Region (2013-2018) Figure United States Premature Labor Treatment Sales Share by Region (2013-2018) Figure United States Premature Labor Treatment Sales Market Share by Region in 2017 Table United States Premature Labor Treatment Revenue (Million USD) and Market Share by Region (2013-2018) Table United States Premature Labor Treatment Revenue Share by Region (2013-2018) Figure United States Premature Labor Treatment Revenue Market Share by Region (2013-2018) Figure United States Premature Labor Treatment Revenue Market Share by Region in 2017 Table United States Premature Labor Treatment Price (USD/Pcs) by Region (2013-2018) Table United States Premature Labor Treatment Sales (K Pcs) by Type (2013-2018) Table United States Premature Labor Treatment Sales Share by Type (2013-2018) Figure United States Premature Labor Treatment Sales Share by Type (2013-2018) Figure United States Premature Labor Treatment Sales Market Share by Type in 2017 Table United States Premature Labor Treatment Revenue (Million USD) and Market Share by Type (2013-2018) Table United States Premature Labor Treatment Revenue Share by Type (2013-2018) Figure Revenue Market Share of Premature Labor Treatment by Type (2013-2018) Figure Revenue Market Share of Premature Labor Treatment by Type in 2017 Table United States Premature Labor Treatment Price (USD/Pcs) by Types (2013-2018) Figure United States Premature Labor Treatment Sales Growth Rate by Type (2013-2018) Table United States Premature Labor Treatment Sales (K Pcs) by Application (2013-2018) Table United States Premature Labor Treatment Sales Market Share by Application (2013-2018) Figure United States Premature Labor Treatment Sales Market Share by Application (2013-2018) Figure United States Premature Labor Treatment Sales Market Share by Application in 2017 Table United States Premature Labor Treatment Sales Growth Rate by Application (2013-2018) Figure United States Premature Labor Treatment Sales Growth Rate by Application (2013-2018) Table AMAG Pharmaceuticals Inc Basic Information List Table AMAG Pharmaceuticals Inc Premature Labor Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure AMAG Pharmaceuticals Inc Premature Labor Treatment Sales Growth Rate (2013-2018) Figure AMAG Pharmaceuticals Inc Premature Labor Treatment Sales Market Share in United States (2013-2018) Figure AMAG Pharmaceuticals Inc Premature Labor Treatment Revenue Market Share in United States (2013-2018) Table GlaxoSmithKline Plc Basic Information List Table GlaxoSmithKline Plc Premature Labor Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure GlaxoSmithKline Plc Premature Labor Treatment Sales Growth Rate (2013-2018) Figure GlaxoSmithKline Plc Premature Labor Treatment Sales Market Share in United States (2013-2018) Figure GlaxoSmithKline Plc Premature Labor Treatment Revenue Market Share in United States (2013-2018) Table Juniper Pharmaceuticals Inc Basic Information List Table Juniper Pharmaceuticals Inc Premature Labor Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Juniper Pharmaceuticals Inc Premature Labor Treatment Sales Growth Rate (2013-2018) Figure Juniper Pharmaceuticals Inc Premature Labor Treatment Sales Market Share in United States (2013-2018) Figure Juniper Pharmaceuticals Inc Premature Labor Treatment Revenue Market Share in United States (2013-2018) Table Kissei Pharmaceutical Co Ltd Basic Information List Table Kissei Pharmaceutical Co Ltd Premature Labor Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Kissei Pharmaceutical Co Ltd Premature Labor Treatment Sales Growth Rate (2013-2018) Figure Kissei Pharmaceutical Co Ltd Premature Labor Treatment Sales Market Share in United States (2013-2018) Figure Kissei Pharmaceutical Co Ltd Premature Labor Treatment Revenue Market Share in United States (2013-2018) Table Lipocine Inc Basic Information List Table Lipocine Inc Premature Labor Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Lipocine Inc Premature Labor Treatment Sales Growth Rate (2013-2018) Figure Lipocine Inc Premature Labor Treatment Sales Market Share in United States (2013-2018) Figure Lipocine Inc Premature Labor Treatment Revenue Market Share in United States (2013-2018) Table ObsEva SA Basic Information List Table ObsEva SA Premature Labor Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure ObsEva SA Premature Labor Treatment Sales Growth Rate (2013-2018) Figure ObsEva SA Premature Labor Treatment Sales Market Share in United States (2013-2018) Figure ObsEva SA Premature Labor Treatment Revenue Market Share in United States (2013-2018) Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Premature Labor Treatment Figure Manufacturing Process Analysis of Premature Labor Treatment Figure Premature Labor Treatment Industrial Chain Analysis Table Raw Materials Sources of Premature Labor Treatment Major Players/Suppliers in 2017 Table Major Buyers of Premature Labor Treatment Table Distributors/Traders List Figure United States Premature Labor Treatment Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025) Figure United States Premature Labor Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure United States Premature Labor Treatment Price (USD/Pcs) Trend Forecast (2018-2025) Table United States Premature Labor Treatment Sales Volume (K Pcs) Forecast by Type (2018-2025) Figure United States Premature Labor Treatment Sales Volume (K Pcs) Forecast by Type (2018-2025) Figure United States Premature Labor Treatment Sales Volume (K Pcs) Forecast by Type in 2025 Table United States Premature Labor Treatment Sales Volume (K Pcs) Forecast by Application (2018-2025) Figure United States Premature Labor Treatment Sales Volume (K Pcs) Forecast by Application (2018-2025) Figure United States Premature Labor Treatment Sales Volume (K Pcs) Forecast by Application in 2025 Table United States Premature Labor Treatment Sales Volume (K Pcs) Forecast by Region (2018-2025) Table United States Premature Labor Treatment Sales Volume Share Forecast by Region (2018-2025) Figure United States Premature Labor Treatment Sales Volume Share Forecast by Region (2018-2025) Figure United States Premature Labor Treatment Sales Volume Share Forecast by Region in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources